CIK 0000014272 · Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 220790350
- Phone
- 6092524621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-10 | BOERNER CHRISTOPHER S. Chief Executive Officer | Shares withheld for taxes | −2,794 | $63.11 | $176K | 110,470 |
| 2025-03-10 | BOERNER CHRISTOPHER S. Chief Executive Officer | Option exercise | +6,733 | 117,203 | ||
| 2025-03-10 | BOERNER CHRISTOPHER S. Chief Executive Officer | Other disposition | −1,147 | 116,056 | ||
| 2025-03-10 | BOERNER CHRISTOPHER S. Chief Executive Officer | Shares withheld for taxes | −2,858 | $63.11 | $180K | 113,198 |
| 2025-03-10 | BOERNER CHRISTOPHER S. Chief Executive Officer | Option exercise | +39,700 | 152,898 | ||
| 2025-03-10 | BOERNER CHRISTOPHER S. Chief Executive Officer | Other disposition | −14,641 | 138,257 | ||
| 2025-03-10 | BOERNER CHRISTOPHER S. Chief Executive Officer | Shares withheld for taxes | −12,818 | $63.11 | $809K | 125,439 |
| 2025-03-10 | BOERNER CHRISTOPHER S. Chief Executive Officer | Option exercise · Market Share Units | −6,985 | 0 | ||
| 2025-03-10 | BOERNER CHRISTOPHER S. Chief Executive Officer | Option exercise · Market Share Units | −6,616 | 6,618 | ||
| 2025-03-10 | BOERNER CHRISTOPHER S. Chief Executive Officer | Option exercise · Market Share Units | −6,733 | 13,466 | ||
| 2025-03-10 | BOERNER CHRISTOPHER S. Chief Executive Officer | Grant or award · Market Share Units | +97,071 | 97,071 | ||
| 2025-03-10 | BOERNER CHRISTOPHER S. Chief Executive Officer | Option exercise · Performance Shares | −39,700 | 0 | ||
| 2025-03-10 | BOERNER CHRISTOPHER S. Chief Executive Officer | Grant or award · Performance Shares | +145,607 | 145,607 | ||
| 2025-03-01 | Hickey Benjamin President, RayzeBio Org. | Option exercise | +3,286 | 10,419 | ||
| 2025-03-01 | Hickey Benjamin President, RayzeBio Org. | Shares withheld for taxes | −1,630 | $59.62 | $97K | 8,789 |
| 2025-03-01 | Hickey Benjamin President, RayzeBio Org. | Option exercise · Restricted Stock Units | −3,286 | 6,572 | ||
| 2025-02-20 | BOERNER CHRISTOPHER S. Chief Executive Officer | Purchase | +2,000 | $55.05 | $110K | 104,626 |
| 2025-02-14 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Purchase | +1,823.49 | $54.84 | $100K | 63,932.49 |
| 2025-02-01 | YALE PHYLLIS R Director | Grant or award · Deferred Share Units | +3,562.34 | $58.95 | $210K | 34,677.2 |
| 2025-02-01 | Vousden Karen H Director | Grant or award · Deferred Share Units | +3,562.34 | $58.95 | $210K | 35,232.04 |
Page 26 of 40 · 799 trades